Changes in Drug‐Induced Hospitalisations and Deaths During the First Year of the Covid ‐19 Pandemic in Australia
Datos Bibliográficos
Confidence interval · Drug · Heroin · Medical prescription · Mortality rate · Pandemic · Psychiatry · Cannabis and Cannabinoid Research · COVID-19 and healthcare impacts · Demography · Medicine · Opioid Use Disorder Treatment · Emergency Medicine · Internal Medicine · Pharmacology
Challenges in maintaining treatment services for people who use drugs during the Covid-19 pandemic
Bidirectional associations between Covid-19 and psychiatric disorder
Strengthening the reporting of observational studies in epidemiology (STROBE) statement
Mental distress among U.S. adults during the Covid‐19 pandemic
Mental health outcomes of quarantine and isolation for infection prevention
Impact of Covid-19 pandemic on utilisation of healthcare services
The psychological impact of quarantine and how to reduce it
Multidisciplinary research priorities for the Covid-19 pandemic
Trends in deaths following drug use in England before, during, and after the Covid-19 lockdowns
Health service utilisation and access for people who inject drugs during Covid ‐19
Illicit drug use and harms in Australia in the context of Covid ‐19 and associated restrictions
Opioid agonist treatment and patient outcomes during the Covid ‐19 pandemic in south east Sydney, Australia
Overdose deaths and the Covid ‐19 pandemic in British Columbia, Canada
Excess Alcohol‐Induced Hospitalisations and Deaths During the First Year of the Covid ‐19 Pandemic in Australia
Patterns of Suicide in the Context of Covid-19
Experience of Healthcare Access in Australia during the First Year of the Covid-19 Pandemic
Increased solitary drug use during Covid-19
Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the Covid-19 pandemic and associated restrictions
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |